Certara Launches DIDB Concomitant Meds Navigator
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage DDI risk in clinical trials.| Certara
The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode the e-mail address.| www.certara.com
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage DDI risk in clinical trials.| Certara
Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights, MIDD, and drug discovery trends.| Certara
Certara joins the Veeva AI Partner Program to integrate CoAuthor™ generative AI with Veeva RIM, simplifying medical writing workflows for life sciences organizations.| Certara
